Skip to main content

Table 3 Data collection summary

From: A role for pharmacists in community-based post-discharge warfarin management: protocol for the 'the role of community pharmacy in post hospital management of patients initiated on warfarin' study

Data

Time point

 

Baseline

Visit 1

Visit 2*

Visit 3i or Day 8c

Day 90

Demographics, alcohol intake, smoking history, drug history, height, weight, serum creatinine, haematocrit

✓

    

Warfarin therapy details- indication, intended duration, target INR, newly commenced or continuing, heparin pre-treatment, inpatient doses/INRs, doses/INR on discharge, warfarin counselling documented

✓

    

Medications, warfarin drug interactions

✓

  

✓

✓

Medical history

✓

    

INR

✓

✓**

✓**

✓**

✓

Warfarin dosing/INR history

✓

  

✓

✓

Number of GP consultations (since discharge, or between Days 8 and 90)

   

✓

✓

Adverse events, hospital readmissions

   

✓

✓

Warfarin continuing, reason for discontinuation

 

✓

✓

✓

✓

Beyth Bleeding Risk score

✓C

✓I

   

Warfarin dose, changes recommended, visit outcome, visit length, travel time

 

✓

✓

✓

 

QoL (EQ-5D), warfarin knowledge

 

✓

 

✓

✓

QoL (Duke Anticoagulation Satisfaction Scale (DASS))

    

✓

Adherence (Tool for Adherence Behaviour Screening (TABS))

   

✓

✓

Self-reported health services utilisation

    

✓

  1. (* Visit 2 if required, ** POC monitoring, C Control, I Intervention)